Back to the calendar
Introducing a novel excipient to formulate poorly soluble APIs and injectable depots

Eastman BioSustane™ SAIB NF is a multifunctional, novel excipient already in approved formulations.

Selecting the right excipient is so important in the drug development process. Join us for a webinar if you’re dealing with poorly water-soluble APIs or are interested in a new excipient for injectable, extended-release dosages.

Live webinar
Date: Thursday, May 12, 2022
Time: 10 a.m. EDT, 2 p.m. UTC
Presenters: Dr. Walter Thompson, Application Development Lead; Dr. Phil Cook, Technical Service Associate


Why attend?
Formulations containing BioSustane have been approved by the U.S. FDA and by regulatory authorities in Taiwan. To help you make an informed decision, we’ll share details on BioSustane’s chemistry, safety, working mechanisms, formulation methods, solubility and stability studies, formulations, and bioavailability studies. You’ll learn:

  • How to formulate poorly water-soluble APIs
  • How to formulate injectable depots
  • More about approved drug formulations and BioSustane's manufacturing and regulatory status

You’ll also connect with Eastman’s highly experienced chemists who are eager to answer your questions and discuss your formulation challenges.

May 12
10:00am - 11:00am
39658 Mission Boulevard,
free webinar